Real-Time Impact of COVID-19 on Clinical Care and Treatment of Patients with Tuberculosis: A Multicenter Cross-Sectional Study in Addis Ababa, Ethiopia.
Dagmawi ChilotYimtubezinash Woldeamanuel MulateTsegahun ManyazewalPublished in: Annals of global health (2021)
COVID-19 significantly hampered the clinical care and treatment of patients with TB. The impact was primarily on their appointments for scheduled medication refills, clinical follow-ups, and laboratory follow-ups. Fear of getting infected with COVID-19, limited access to transportation, reduced income for traveling to health facilities, costs for personal protective equipment and traveling to healthcare facilities, and the lockdown were the major determinants. The impact could be mitigated by reducing the number of visits, rationing personal protective equipment as feasible, compensating travel expenses, providing health educations and community-based TB services, and maintaining TB services.
Keyphrases
- healthcare
- coronavirus disease
- sars cov
- mycobacterium tuberculosis
- mental health
- primary care
- public health
- palliative care
- health information
- physical activity
- pain management
- clinical trial
- cross sectional
- chronic pain
- combination therapy
- replacement therapy
- hiv aids
- climate change
- human immunodeficiency virus
- drug induced